INNOVATION
Novilytic is developing for the future. It’s growth is focused on four separate markets. They are:
-
Proteometers Consumables: This market is the focus of our business plan and a $500M market. The product pipeline (available to investors) will continue to produce more value over time.
-
Patented Consumables: The Proteometer™ consumables also represent additional market value for selling our consumables and licensing technology in other analytical markets. Examples of this include the following targets:
-
Proteometer Medical Device: The Proteometer is an easy to use yet very capable detector of various proteins. Diseases, Viruses, and other key analytes can be detected using the Proteometer.
-
Affinity Selection Columns: Our patented-protected columns and methods provide opportunities for separation and selection IP for chromatography markets. These include water analysis, industrial and food markets, etc.
-
Reagent IP: Similar to the affinity selection columns, our reagents and associated methods IP will allow us to sell Proteometer reagents in other markets.
-
NoviPlex™ Plasma Cards: The NoviPlex™ cards represent a significant improvement in plasma processing, especially for remote monitoring in foreign and 3rd World countries. We will continue to grow this product line through partnerships with key analytical companies.
-
New Medical Device Tech: This new technology, already protected by our patents, will allow diagnosis off of the NoviPlex card. The market value of this new technology is >$1B as it will compete against the likes of Roche Diagnostics, Abbott Healthcare, and other POC devices.